mary555

Author Archives

Recent Author Comments

On Microblog: Solving New Mampilly Teaser: “Could this topple Ford, Toyota, and Tesla?”
Sure, Krshr: mmqc555@gmail.com[...]
On Profits Unlimited
Richard, I believe what he means to say is that he is limiting the new offer to the first 500 subscribers. He is offering it to everyone but will close the offering when enough people sign up. With these high risk/potentially high-profit small cap stoc[...]
On "Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA"
ee - I believe the rats ingested the vanillin. I don't know that rubbing it on the skin would do anything. Here is an excerpt: "The researchers induced psoriatic skin inflammation on groups of mice by putting a compound called imiquimod on their skin. In[...]
On Microblog: Performance of Mampilly's "True Momentum" and "Extreme Fortunes" Premium Newsletters
I spent a good bit of time on this one but have not solved it yet. I think that PM caught on that we are playing Robin Hood by solving and posting his picks on Stockgumshoe. He has limited the clues accordingly. My best guess is that it is a regtech fir[...]
On Microblog: Solving New Mampilly Teaser: “Could this topple Ford, Toyota, and Tesla?”
Thanks for the confirmation, Carl. I'd love to chat with you about your experience with True Momentum. If you want to send me an email, I can be reached at mmqc555@gmail.com. All the best, Mary.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Paul Mampilly's True Momentum pick, which will be released shortly, is SRPT Sarepta Therapeutics. It has been climbing for several days on earnings beat and other news. This is not investment advice. I just like to solve puzzles ; ) I'm long CAPR myself b[...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
As promised: Paul’s True Momentum Pick, which will be released shortly, is SRPT Sarepta Therapeutics. It has been climbing for several days on earnings beat and other news. This is not investment advice. I just like to solve puzzles ; )[...]
On Microblog: Solving New Mampilly Teaser: “Could this topple Ford, Toyota, and Tesla?”
Paul's True Momentum Pick, which will be released shortly, is SRPT Sarepta Therapeutics. It has been climbing for several days on earnings beat and other news. This is not investment advice. I just like to solve puzzles ; )[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Yes, and the reason women lack visual-spatial skills is that all of our lives we've been told that this https://www.google.com/search?q=images+hillary+clinton+fingers&source=lnms&tbm=isch&sa=X&ved=0ahUKEwjJltOjrabXAhVBTGMKHVz2DeIQ_AUICigB[...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
OOPS! I've been up all night working on a research proposal. I gave you the wrong email address. Let me know if the one you sent bounces back. There might be another Mary out there scratching her head right now ; ) Here is the correct email for me: mm[...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
PS One of the reasons I stay with Profits Unlimited is that Paul Mampilly shares all of the trades including the losses and closed out positions so one can get a realistic picture of how PU is doing. You can also get an idea of the sectors he's good (or [...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
Hi Moonlight, I have solved this one and plan to post it Monday morning after the market opens and I have placed a small trade. Please send me an email if you would like to discuss at mary555@gmail.com. Happy sleuthing and trading to all![...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
Hi Moonlight, I too think that P.M.s entry level newsletter is a best-buy at only 47 dollars a year (plus an additional 39.00 for the second year if you sign up for both at one time). I would pay 100 to 200 dollars a year for it if I didn't come wrapped i[...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
Hi deano1, It's not a six million dollar company. It had 6 million in revenues and the company is EDIT . This is an old teaser that they are recycling. If you look at the stock, it peaked in Feb. on the news that they won the lawsuit but all three of [...]
On "Greatest Medical Breakthrough in History" from Paul Mampilly
Hi kit rens, On what date/s did Mampilly promote FMI? Did it fall afterward (i.e. pump and dump)? I'm not a member of True Momentums but I did figure out one of his picks beforehand and bought it --NTNX at 21.5 That one has done very well and just con[...]
On Tear Sheet: CohBar Inc. ($CWBR)
$ PTN Thank you, Lannas.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
$PTN Sorry, petervr, I'm new here. Thank you for your help and please ignore the second post regarding PTN. I wasn't trying to nag, it was just that the first post disappeared for awhile.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Were they granted the extended patent? The website says that the composition of matter patents expire in 2020.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Thanks for the update, Roblites. Interesting product and looks like an undervalued company but I am concerned about the compositions of matter patents expiring in late 2020. Were they granted the extension to 2033? If so, is the extended patent for BMT or[...]
On Microblog: Solving New Mampilly Teaser: “Could this topple Ford, Toyota, and Tesla?”
Welcome, Michale! Is the new service you joined another Mampilly offering? I like FEYE and am thinking about investing in it but wondering if the smarter bet wouldn't be to find a good ETF with the top cybersecurity stocks in it. Has anyone else gone [...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.